NASDAQ:IART

Integra Lifesciences Holdings Stock News

etoro logo Buy IART
*Your capital is at risk
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Stre
Integra LifeSciences (IART) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.97 per share a year ago.
PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) --  Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,
PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Teshtar Ela
PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 202
Shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART - Get Free Report) have been given a consensus rating of "Reduce" by the seven brokerages that are presently covering the stock, Marke
Access Investment Management LLC reduced its stake in Integra LifeSciences Holdings Corporation (NASDAQ: IART) by 14.6% during the third quarter, according to its most recent 13F filing with the Secur
Hussman Strategic Advisors Inc. purchased a new stake in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) in the undefined quarter, according to its most recent filing with the Secur
FMS, IART and STE trade below historical valuations. Easing cost pressure and improved execution set the stage for potential upside in 2026 for these companies.
Integra LifeSciences Holdings Corporation (IART) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART - Get Free Report) have earned an average rating of "Reduce" from the seven research firms that are currently covering the company, Ma
PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer M
Assenagon Asset Management S.A. lessened its stake in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) by 62.0% in the undefined quarter, according to the company in its most recent
Integra LifeSciences Holdings Corporation (IART) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer M
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE